Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia.

Zhao, Bo; Yu, Xiaoxu; Chen, Rui; Zheng, Rui

Zhao, Bo; Yu, Xiaoxu; Chen, Rui; Zheng, Rui.

Afiliación

Zhao B; Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, People's Republic of China.
Yu X; Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, People's Republic of China.
Chen R; Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, People's Republic of China.
Zheng R; Department of Pulmonary and Critical Care Medicine, Shengjing Hospital of China Medical University, Shenyang 110004, Liaoning Province, People's Republic of China.

Infect Drug Resist ; 13: 2099-2104, 2020.

Article en En | MEDLINE | ID: mdl-32669862

Palabras clave

CRB-65 score; monotherapy; symptom improvement; tolerability

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Infect Drug Resist Año: 2020 Tipo del documento: Article Pais de publicación: Nueva Zelanda

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google